ClinicalTrials.gov
public full text
Public Domain
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- Role of Pentraxin-3 in Assessment of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus#427409
- The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria#1172962
- Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)#253166
- Urinary podocalyxin as an early biomarker for diabetic nephropathy.#395950
- Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy#422396
Record · ID 353407 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive